AMOXICILLIN PEDIATRIC Drug Patent Profile
✉ Email this page to a colleague
When do Amoxicillin Pediatric patents expire, and what generic alternatives are available?
Amoxicillin Pediatric is a drug marketed by Teva and is included in one NDA.
The generic ingredient in AMOXICILLIN PEDIATRIC is amoxicillin. There are forty-six drug master file entries for this compound. Thirty-five suppliers are listed for this compound. Additional details are available on the amoxicillin profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Amoxicillin Pediatric
A generic version of AMOXICILLIN PEDIATRIC was approved as amoxicillin by TEVA on December 22nd, 1992.
Summary for AMOXICILLIN PEDIATRIC
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Finished Product Suppliers / Packagers: | 6 |
Raw Ingredient (Bulk) Api Vendors: | 69 |
Clinical Trials: | 561 |
Patent Applications: | 1,017 |
Formulation / Manufacturing: | see details |
DailyMed Link: | AMOXICILLIN PEDIATRIC at DailyMed |
Recent Clinical Trials for AMOXICILLIN PEDIATRIC
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
University of Missouri-Columbia | Phase 4 |
Abdul El-Rabbany | Phase 4 |
TenNor Therapeutics (Suzhou) Limited | Phase 3 |
Pharmacology for AMOXICILLIN PEDIATRIC
Drug Class | Penicillin-class Antibacterial |
Anatomical Therapeutic Chemical (ATC) Classes for AMOXICILLIN PEDIATRIC
US Patents and Regulatory Information for AMOXICILLIN PEDIATRIC
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Teva | AMOXICILLIN PEDIATRIC | amoxicillin | FOR SUSPENSION;ORAL | 061931-003 | Dec 1, 1982 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |